India has vaccinated more than 10.5 million health and front-line workers since beginning its immunisation campaign on January 16

Located in the city of Pune in Maharashtra, the SII is the world's largest vaccine manufacturer by volume

Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week

Data analysed by Public Health England (PHE) showed the Pfizer provided high levels of protection against infection and symptomatic disease from a single dose

Poonawalla appealed to countries and governments to be patient and assured that the coronavirus vaccine will be available to the rest of the world who are purchasing the AstraZeneca-Oxford doses from India

On Saturday, coronavirus vaccine shots were administered to over 26,000 beneficiaries in Delhi, the inoculation figures crossing the 24,000-mark for the third consecutive day

Pakistan Health Minister Faisal Sultan said that COVAX would provide 2.8 million doses of Oxford AstraZeneca on March 2, enabling the vaccination of older people

Symptoms, as reported in clinical trials for the AstraZeneca shot, can include a high temperature or headache and are a normal sign that the body is generating an immune response

In this meeting, the NTAGI will review the World Health Organisation's (WHO) recommendation to extend the gap between two doses of the AstraZeneca- Oxford vaccine from 4 weeks to 8-12 weeks

External Affairs Minister S Jaishankar, while addressing the UN Security Council meeting on COVID-19 on Wednesday, announced a gift of 200,000 COVID-19 doses for the UN peacekeepers

The vaccines currently approved for emergency use in India are Covishield, from the Oxford-AstraZeneca stable manufactured by Pune's Serum Institute of India, and Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology (NIV)

Having reported the highest number of coronavirus infections after the United States, and with the world's biggest vaccine-making capacity, India says it has been the fastest to reach many inoculation milestones

AstraZeneca has said its vaccine appeared to offer only limited protection against mild disease caused by the South African variant

Serum Institute has applied for registration with Health Canada with the help of Toronto-based Verity Pharmaceuticals, Adar Poonawalla said

South Korea had said it would complete vaccinations on 1.3 million people by the first quarter of this year with AstraZeneca shots, but it slashed the target sharply to 750,000

Chhattisgarh CM had raised two primary concerns regarding Covaxin -- inhibitions on incomplete trials and absence of \"expiration date\". Dr Vardhan says vaccine approved after due evaluation of pre-clinical and clinical trial data and that expiry date is mentioned on its label

The Anglo-Swedish drugmaker worked with Oxford to develop one of the first COVID-19 vaccines authorised for widespread use. AstraZeneca said it hopes to cut the time needed to produce large amounts of any new vaccine to between six and nine months

Professor Sharon Peacock, head of UK's genetic surveillance progragramme, said that once the virus mutates itself out of being virulent then one can stop worrying about it

WHO highlighted the need to reduce virus circulation and prevent infections so that it reduces the opportunities for coronavirus to mutate further.

Adani Group completes acquisition of 23.5% stake in Mumbai Airport; to hike ownership to 74% Billionaire Gautam Adani-led Adani Group has completed acquisition of 23.5 per cent equity stake in Mumbai International Airport Limited (MIAL) from Airports Company South Africa (ACSA) and Bid Services Division (Mauritius) Limited for Rs 1,685.2 crore. The Indian multinational conglomerate is set to extend shareholding to 74 per cent in MIAL, a joint venture between the Airports Authority of India ...